Home Cart Sign in  
Chemical Structure| 93919-56-3 Chemical Structure| 93919-56-3

Structure of 93919-56-3

Chemical Structure| 93919-56-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Datta, Magdalena ; Szczyrba, Adrian ; Czaja, Anna ; Zdrowowicz, Magdalena ; Demkowicz, Sebastian ; Rak, Janusz

Abstract: To verify whether the recently synthesized nucleoside, 8-(4-Trifluoromethoxy)benzylamino-2′-deoxyadenosine, can sensitize tumorous cells to X-rays, radiolytic and in vitro studies have been conducted. Molecular modeling demonstrated that excess electrons should lead to efficient dissociative electron attachment (DEA) to dA-NHbenzylOCF3 resulting in a radical product that can potentially damage DNA. The computationally predicted DEA process was confirmed via stationary radiolysis of a dA-NHbenzylOCF3 water solution followed by LC-MS analysis of the obtained radiolytes. Moreover, dA-NHbenzylOCF3 was tested against its cytotoxicity and clonogenicity. We showed that the modified nucleoside is not cytotoxic to PC3, MCF-7, and HaCaT cell lines. Additionally, the clonogenic test exhibited a statistically significant radiosensitization of PC3 and MCF-7 cells to X-rays. On the other hand, flow cytometry assays demonstrated that the action of dA-NHbenzylOCF3 is related to its influence on the cell cycle rather than the level of DNA double-strand breaks induced by ionizing radiation. Our findings indicate that the compound enters the cell and predominantly localizes in the cytoplasm, with a notable amount also detected in the nucleus. Moreover, we established that the compound is not phosphorylated by cellular kinases nor integrated into genomic DNA by the replication machinery.

Keywords: Radiosensitizing nucleosides ; Dissociative electron attachment ; Clonogenic assay ; MTT test ; Cell cycle

Purchased from AmBeed: ;

Alternative Products

Product Details of [ 93919-56-3 ]

CAS No. :93919-56-3
Formula : C8H8F3NO
M.W : 191.15
SMILES Code : NCC1=CC=C(OC(F)(F)F)C=C1
MDL No. :MFCD00061237
InChI Key :DBGROTRFYBSUTR-UHFFFAOYSA-N
Pubchem ID :571846

Safety of [ 93919-56-3 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H227-H315-H319-H335
Precautionary Statements:P305+P351+P338

Computational Chemistry of [ 93919-56-3 ] Show Less

Physicochemical Properties

Num. heavy atoms 13
Num. arom. heavy atoms 6
Fraction Csp3 0.25
Num. rotatable bonds 3
Num. H-bond acceptors 5.0
Num. H-bond donors 1.0
Molar Refractivity 40.8
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

35.25 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

2.03
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

1.96
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

3.15
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

1.68
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

2.0
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

2.16

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-2.4
Solubility 0.755 mg/ml ; 0.00395 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-2.33
Solubility 0.904 mg/ml ; 0.00473 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-3.07
Solubility 0.162 mg/ml ; 0.000845 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.07 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.15

Application In Synthesis of [ 93919-56-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 93919-56-3 ]

[ 93919-56-3 ] Synthesis Path-Downstream   1~2

  • 1
  • [ 149057-19-2 ]
  • [ 93919-56-3 ]
  • [ 1311150-46-5 ]
  • 2
  • [ 440627-14-5 ]
  • [ 93919-56-3 ]
  • C22H15F3N2O3S [ No CAS ]
YieldReaction ConditionsOperation in experiment
[000214] To a stirred solution of 6 (40 mg, 0.14 mmol) in DMF (3 mL) under argon atmosphere was added CDI (71.7 mg, 0.17 mmol) at 0 C; warmed to RT and stirred for 2 h. To this were added (4-(trifluoromethoxy) phenyl) methanamine 172 (33.8 mg, 0.17 mmol), and diisopropyl ethyl amine (0.05 mL, 0.29 mmol) and stirred for 16 h. The reaction was monitored by TLC; after completion of the reaction, the reaction mass was diluted with water (15 mL) and stirred for 1 h. The precipitate was filtered or extracted with EtOAc or CH2C12 and the obtained solid was dried in vacuo or purified by column chromatography or triturated to afford the desired product.
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 93919-56-3 ]

Fluorinated Building Blocks

Chemical Structure| 175205-64-8

A514421 [175205-64-8]

(2-(Trifluoromethoxy)phenyl)methanamine

Similarity: 0.96

Chemical Structure| 1208989-29-0

A108600 [1208989-29-0]

(R)-1-(4-(Trifluoromethoxy)phenyl)ethanamine hydrochloride

Similarity: 0.92

Chemical Structure| 1391540-47-8

A255592 [1391540-47-8]

(S)-1-(4-(Trifluoromethoxy)phenyl)ethanamine hydrochloride

Similarity: 0.92

Chemical Structure| 170015-99-3

A141040 [170015-99-3]

2-(4-(Trifluoromethoxy)phenyl)ethanamine

Similarity: 0.90

Chemical Structure| 86256-59-9

A267881 [86256-59-9]

2-Methyl-4-(trifluoromethoxy)aniline

Similarity: 0.87

Aryls

Chemical Structure| 175205-64-8

A514421 [175205-64-8]

(2-(Trifluoromethoxy)phenyl)methanamine

Similarity: 0.96

Chemical Structure| 1208989-29-0

A108600 [1208989-29-0]

(R)-1-(4-(Trifluoromethoxy)phenyl)ethanamine hydrochloride

Similarity: 0.92

Chemical Structure| 1391540-47-8

A255592 [1391540-47-8]

(S)-1-(4-(Trifluoromethoxy)phenyl)ethanamine hydrochloride

Similarity: 0.92

Chemical Structure| 170015-99-3

A141040 [170015-99-3]

2-(4-(Trifluoromethoxy)phenyl)ethanamine

Similarity: 0.90

Chemical Structure| 86256-59-9

A267881 [86256-59-9]

2-Methyl-4-(trifluoromethoxy)aniline

Similarity: 0.87

Ethers

Chemical Structure| 175205-64-8

A514421 [175205-64-8]

(2-(Trifluoromethoxy)phenyl)methanamine

Similarity: 0.96

Chemical Structure| 1208989-29-0

A108600 [1208989-29-0]

(R)-1-(4-(Trifluoromethoxy)phenyl)ethanamine hydrochloride

Similarity: 0.92

Chemical Structure| 1391540-47-8

A255592 [1391540-47-8]

(S)-1-(4-(Trifluoromethoxy)phenyl)ethanamine hydrochloride

Similarity: 0.92

Chemical Structure| 170015-99-3

A141040 [170015-99-3]

2-(4-(Trifluoromethoxy)phenyl)ethanamine

Similarity: 0.90

Chemical Structure| 86256-59-9

A267881 [86256-59-9]

2-Methyl-4-(trifluoromethoxy)aniline

Similarity: 0.87

Amines

Chemical Structure| 175205-64-8

A514421 [175205-64-8]

(2-(Trifluoromethoxy)phenyl)methanamine

Similarity: 0.96

Chemical Structure| 1208989-29-0

A108600 [1208989-29-0]

(R)-1-(4-(Trifluoromethoxy)phenyl)ethanamine hydrochloride

Similarity: 0.92

Chemical Structure| 1391540-47-8

A255592 [1391540-47-8]

(S)-1-(4-(Trifluoromethoxy)phenyl)ethanamine hydrochloride

Similarity: 0.92

Chemical Structure| 170015-99-3

A141040 [170015-99-3]

2-(4-(Trifluoromethoxy)phenyl)ethanamine

Similarity: 0.90

Chemical Structure| 86256-59-9

A267881 [86256-59-9]

2-Methyl-4-(trifluoromethoxy)aniline

Similarity: 0.87

Trifluoromethyls

Chemical Structure| 175205-64-8

A514421 [175205-64-8]

(2-(Trifluoromethoxy)phenyl)methanamine

Similarity: 0.96

Chemical Structure| 1208989-29-0

A108600 [1208989-29-0]

(R)-1-(4-(Trifluoromethoxy)phenyl)ethanamine hydrochloride

Similarity: 0.92

Chemical Structure| 1391540-47-8

A255592 [1391540-47-8]

(S)-1-(4-(Trifluoromethoxy)phenyl)ethanamine hydrochloride

Similarity: 0.92

Chemical Structure| 170015-99-3

A141040 [170015-99-3]

2-(4-(Trifluoromethoxy)phenyl)ethanamine

Similarity: 0.90

Chemical Structure| 86256-59-9

A267881 [86256-59-9]

2-Methyl-4-(trifluoromethoxy)aniline

Similarity: 0.87